Drug Shortage Report for DILTIAZEM HYDROCHLORIDE INJECTION
Report ID | 189684 |
Drug Identification Number | 02514095 |
Brand name | DILTIAZEM HYDROCHLORIDE INJECTION |
Common or Proper name | Diltiazem Hydrochloride Injection |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 x 10 mL vial / fiole |
ATC code | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-05-26 |
Estimated end date | |
Actual end date | 2023-09-01 |
Shortage status | Resolved |
Updated date | 2023-09-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.